Pinealon: mainly used in scientific research related to neuroprotection

Cas: 175175-23-2

Molecular formula: C15H26N6O8

Molecular weight: 418.4

Pinealon is a short peptide composed of three amino acids. In some research literature, Pinealon is described as a peptide with antioxidant activity. Because it is a class of small-molecule peptides, it can directly interact with the cell genome.

Original Research Institute:

The original research team for Pinealon is a Russian research team, mainly related to Professor Vladimir Khavinson and his team.

This peptide is the result of Russia's "Peptide-Gene Regulation" research program, developed by the St. Petersburg Institute of Biological Regulation and Gerontology.

Pinealon is one of a series of short peptide "bioregulators" developed by Professor Harvinson's team.

Clinical trials:

There are those with limited scale and a lack of high-quality independent verification.

Regulatory status: Pinealon has not been approved by the U.S. FDA for any medical use and is currently sold only as a research chemical.

Synthesis method:

The standard synthesis method for pinealon is solid-phase peptide synthesis (SPPS).

Anyone need api for research, plz contact us.